Diamyd Medical AB (publ) (FRA:DMN)
Germany
· Delayed Price · Currency is EUR 0.860
-0.005 (-0.58%)
Last updated: Dec 5, 2025, 8:03 AM CET
Diamyd Medical AB Revenue
In the fiscal year ending August 31, 2025, Diamyd Medical AB had annual revenue of 130.00K SEK. Diamyd Medical AB had revenue of 19.00K in the quarter ending August 31, 2025, with 5.56% growth.
Revenue
130.00K SEK
Revenue Growth
n/a
P/S Ratio
10,292.33
Revenue / Employee
3.33K SEK
Employees
39
Market Cap
120.72M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 130.00K | - | - |
| Aug 31, 2024 | 130.00K | -416.00K | -76.19% |
| Aug 31, 2023 | 546.00K | 92.00K | 20.26% |
| Aug 31, 2022 | 454.00K | 201.00K | 79.45% |
| Aug 31, 2021 | 253.00K | -88.00K | -25.81% |
| Aug 31, 2020 | Pro | Pro | Pro |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |